This is a snippet of the transcript, sign up to read more.
Addressing one of your future questions, why would Advent sell it? Well, they couldn't have chosen a better time. When they bought it, Ultra did not have any contracts related to the AUKUS agreement or AUKUS submarines. There were no contracts on the sheets or expected for AUKUS submarines from Ultra. Then, suddenly, all of that happened, and now they're on the sheets. The valuation jumped for reasons unrelated to anything Advent did; it was due to external factors creating a new market in Australia for UK submarines. It was like a blessing. They have the contracts and are working on them at the preliminary stage. When you have a big contract, the only thing that can happen is something goes wrong. From Advent's point of view, they want to get the cash back. They got a good multiplier, a big escalation in expected value, and they put a decent multiplier on it. So, it was a good time for the sale. I'm not surprised it happened.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.